Ophthalmic Devices Market Growth, Demand and Challenges of the Key Industry Players 2024-32
                     Global Ophthalmic 
Devices Market 
Research and Forecast 
Report 2024-2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
Accord ing  t o  t he  l a tes t  repo r t  by  IMARC Group ,  t i t l ed  "Ophthal mic  Dev ices  
Market :  G l oba l  Indust ry  T rends ,  Share ,  S ize ,  Growth ,  O pportun i ty  and  
Forecast  2024-2032 ,"  t he  g loba l  oph t ha lm ic  dev ices  marke t  s i ze  reached US$ 
27 .6  B i l l i on  in  2023.
Report Opht ha lm ic  dev ices  a re  med ica l  dev i ces  tha t  a re  u t i l i zed  fo r  v i s ion  co r rec t ion  and su rg ica l  d iagnos i s ,  rang ing  f rom invas ive  dev ices ,  such  as  con tac t  l enses ,  
imp lan t ab le  dev ices ,  l i ke  in t raocu la r  lenses  and g laucoma s t en ts ,  t o  non - invas ive  
Highlight and dev ices  and  i ns t rumen ts .  
Surg ica l  sys tems ,  inc lud ing  lasers ,  phacoemu ls i f i ca t ion  mach ines ,  and  su rg ica l  
Description i ns t rumen ts ,  a re  a lso  u t i l i zed  by  med ica l  p ro fess iona ls  f o r  d iagnos is ,  su rge ry ,  and  v is ion  co r rec t i on .  They  have ga ined  re levance ac ross  t he  g lobe  due t o  the  
inc reas ing  preva lence  o f  oph tha lm ic  d iseases  and  ocu la r  abnorma l i t i es ,  such  as  
ca ta rac ts ,  g l aucoma,  and o t he r  v i s ion - re la t ed  cond i t i ons .
Request  fo r  a  PDF sample  o f  th is  repor t :  
ht tps : / / www. imarcgroup .com/oph tha lm ic -dev ices -marke t / r eques tsamp le
Report Description
G l o b a l  O p h t h a l m i c  D e v i c e s  M a r k e t  T r e n d s :
T h e  g l o b a l  m a r k e t  i s  p r i m a r i l y  d r i v e n  b y  t h e  i n c r e a s i n g  p r e v a l e n c e  o f  v i s i o n  d i s o r d e r s .  I n  l i n e  w i t h  t h i s ,  r a p i d  t e c h n o l o g i c a l  
a d v a n c e m e n t s  i n  t h e s e  d e v i c e s ,  s u c h  a s  i n t r a o c u l a r  l e n s e s ,  a r e  c r e a t i n g  a  p o s i t i v e  o u t l o o k  f o r  t h e  m a r k e t .  F u r t h e r m o r e ,  t h e  r i s i n g  
n u m b e r  o f  e y e  s u r g e r i e s  w o r l d w i d e  i s  s i g n i f i c a n t l y  c o n t r i b u t i n g  t o  t h e  m a r k e t  g r o w t h .  T h e  l e a d i n g  m a r k e t  p l a y e r s  a r e  f o c u s i n g  o n  
s t r e n g t h e n i n g  t h e i r  r e s e a r c h  a n d  d e v e l o p m e n t  ( R & D )  d o m a i n  f o r  d e v e l o p i n g  n o v e l  d e v i c e s  t o  t r e a t  v i s i o n  e r r o r s ,  w h i c h  i s  e x p e c t e d  t o  
p o s i t i v e l y  i n f l u e n c e  t h e  m a r k e t  e x p a n s i o n .  A p a r t  f r o m  t h i s ,  t h e  i n t r o d u c t i o n  o f  i n n o v a t i v e  e q u i p m e n t ,  c o n s u m a b l e s ,  a n d  c o n t a c t  l e n s e s  
o f f e r  n u m e r o u s  g r o w t h  o p p o r t u n i t i e s  i n  t h e  m a r k e t .  V a r i o u s  m a r k e t  p l a y e r s  f o c u s  o n  p r o d u c i n g  n o v e l  m i c r o - i n v a s i v e  g l a u c o m a  s u r g i c a l  
i m p l a n t s  t h a t  i s  e x p e c t e d  t o  c a t a l y z e  t h e  u p t a k e  o f  o p h t h a l m i c  d e v i c e s .  
M o r e o v e r ,  t h e  g r o w i n g  p r e v a l e n c e  o f  o p h t h a l m i c  d i s o r d e r s ,  i n c l u d i n g  c a t a r a c t s ,  d i a b e t i c  r e t i n o p a t h y ,  m y o p i a ,  a n d  a g e - r e l a t e d  m a c u l a r  
d e g e n e r a t i o n ,  i s  p r o p e l l i n g  t h e  p r o d u c t  d e m a n d .  B e s i d e s ,  f a v o r a b l e  r e i m b u r s e m e n t  p o l i c i e s  f o r  o p h t h a l m i c  p r o c e d u r e s ,  t h e  e s c a l a t i n g  
n u m b e r  o f  o p h t h a l m i c  s u r g e r i e s ,  a n d  t h e  i n f l a t i n g  h e a l t h c a r e  e x p e n d i t u r e  a r e  f a v o r i n g  t h e  m a r k e t .  I n  a d d i t i o n ,  t h e  i n c r e a s i n g  
g o v e r n m e n t  i n i t i a t i v e s  t o  s p r e a d  a w a r e n e s s  r e l a t e d  t o  v i s u a l  i m p a i r m e n t  a r e  p r o j e c t e d  t o  c r e a t e  a  p o s i t i v e  o u t l o o k  f o r  t h e  m a r k e t .
L o o k i n g  f o r w a r d ,  t h e  m a r k e t  i s  a n t i c i p a t e d  t o  r e a c h  a  v a l u e  o f  U S $  3 8 . 5  B i l l i o n  b y  2 0 3 2 ,  e x h i b i t i n g  a  C A G R  o f  3 . 7 %  d u r i n g  2 0 2 4 -
2 0 3 2 .
V i e w  R e p o r t  T O C ,  F i g u r e s  a n d  T a b l e s :  h t t p s : / / w w w . i m a r c g r o u p . c o m / o p h t h a l m i c - d e v i c e s - m a r k e t
Breakup by Product Type:
• Surgical
o Implants
o Consumables
o Equipment
•
Report Vision Care
o Contact Lens
Segmentation o Ocular  Health
 
Breakup by Application:
• Cataract
• Vitreo Ret inal  Disorders
• Glaucoma
• Refractor  Disorders
Breakup by End Use:
• Hospitals and Eye Cl inics
• Academic and Research Laboratory
• Others
Report Breakup by Region:
Segmentation • North America
• Asia-Pacifi c
• Europe
• Latin America
• Middle East and Afr ica
• Bausch & Lomb Incorporated (Bausch 
Health Companies Inc.)
• Carl  Zeiss Meditec AG
•
Competitive Essi lorLuxott ica SA
• Haag-Streit  Group
Landscape • HOYA Surgical Optics GmbH (Hoya 
with Key Corporation)
• Leica Microsystems GmbH (Danaher 
Players Corporation)
• Nidek Co Ltd., Topcon Corporat ion
• Volk Optical  Inc.
• Ziemer Ophthalmic Systems AG
What was the size of the global ophthalmic devices 
market in 2023?
What is the expected growth rate of the global 
ophthalmic devices market during 2024-2032?
What are the key factors driving the global ophthalmic 
Key devices market?
Questions What has been the impact of COVID-19 on the global 
ophthalmic devices market?
Answered in 
What is the breakup of the global ophthalmic devices 
market based on the product type?
the Report
What is the breakup of the global ophthalmic devices 
market based on the end use?
What are the key regions in the global ophthalmic 
devices market?
Who are the key players/companies in the global 
ophthalmic devices market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
        2 . 4 . 1     B o t t o m - U p  A p p r o a c h
Table of         2 . 4 . 2     T o p - D o w n  A p p r o a c h    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
    4 . 1     O v e r v i e w
Contents     4 . 2     K e y  I n d u s t r y  T r e n d s5     G l o b a l  O p h t h a l m i c  D e v i c e s  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  P r o d u c t  T y p e
    6 . 1     S u r g i c a l
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  K e y  S e g m e n t s  
           6 . 1 . 2 . 1  I m p l a n t s
           6 . 1 . 2 . 2  C o n s u m a b l e s
           6 . 1 . 2 . 3  E q u i p m e n t
        6 . 1 . 3  M a r k e t  F o r e c a s t
    6 . 2     V i s i o n  C a r e
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  K e y  S e g m e n t s  
       
                      6 .2 .2 .1  Contact  Lens
                     6 .2 .2 .2  Ocu la r  Hea l th
               6 .2 .3  Market  Fo recas t
7    Market  Breakup by  Appl icat ion
       7 .1       Ca ta ract
               7 .1 .1  Market  Trends
               7 .1 .2  Market  Fo recas t
       7 .2       Vi t reo  Ret ina l  D isorders
               7 .2 .1  Market  Trends
               7 .2 .2  Market  Fo recas t
Table of        7 .3       G laucoma
               7 .3 .1  Market  Trends
               7 .3 .2  Market  Fo recas t
Contents        7 .4       Re f rac to r  D iso rders               7 .4 .1  Market  Trends
               7 .4 .2  Market  Fo recas t
8    Market  Breakup by  End Use
       8 .1       Hosp i ta l s  and  Eye  C l in i cs
               8 .1 .1  Market  Trends
               8 .1 .2  Market  Fo recas t
       8 .2       Academic  and  Research  Laborato ry
               8 .2 .1  Market  Trends
               8 .2 .2  Market  Fo recas t
       8 .3       Others
               8 .3 .1  Market  Trends
               8 .3 .2  Market  Fo recas t
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
ht tps : / /www. imarcgroup .com/oph tha lm ic -dev ices -market / t
oc
Disclaimer
© 2023  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
TELEPHONE: +1-631-791-1145 
E-MAIL: [email protected]